modelPipecuroniumBromide_Yajima1990_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:pipecuronium_bromide
ATC code:M03AC06
model:one compartment, IV dosing (PK_1C)
source:Yajima C et al. 1990
population:male patients
measured compound:pipecuronium_bromide
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
distribution half-life; T1/2 alpha3.9mint1/2α
elimination half-life; T1/2 beta102mint1/2β
volume of the central compartment; V195ml.kg-1V
volume of distribution at steady state; Vdss264ml.kg-1Vss
clearance; Cl1.8ml.min-1.kg-1CL

About pipecuronium_bromide

Pipecuronium bromide is a non-depolarising neuromuscular blocking agent, a muscle relaxant used to relax muscles during surgery. It is no longer in use, having been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q20817188 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Pipecuronium.

References

  1. Yajima C et al. (1990). [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man]. Masui. The Japanese journal of anesthesiology 39(7):882–889. PUBMED:1976829

Parameters

TypeNameDefaultDescription
RealCl_ref2.1e-06Cl [m3/s]
RealVd_ref0.00665Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Yajima_1990: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate